Michigan Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 33 (85% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 8,313
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 35.69%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,099
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 28.39%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 57.43% 64.97%
White, Hispanic/Latino Patients 6.06% 5.10%
Black/African American, Non-Hispanic/Latino Patients 16.87% 13.38%
Black/African American, Hispanic/Latino Patients 0.57% 0.73%
Asian Patients3 0.81% 0.55%
American Indian/Alaska Native Patients3 0.45% 0.45%
Native Hawaiian/Other Pacific Islander Patients3 0.10% 0.00%
Patients with More than one race3 3.13% 2.46%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.90% 3.09%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.24% 1.73%
Unreported/Refused to Report Race and Ethnicity 8.47% 7.55%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,638
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 63.42%
COVID-19 Immunization Series Completed 2,096
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 61.93%
COVID-19 Immunization Series Additional 152
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 8.66%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 32.60% 32.73% 76.32%
White, Hispanic/Latino Patients 14.59% 13.79% 0.66%
Black/African American, Non-Hispanic/Latino Patients 21.18% 18.42% 5.92%
Black/African American, Hispanic/Latino Patients 0.85% 1.19% 0.00%
Asian Patients3 0.73% 0.91% 0.00%
American Indian/Alaska Native Patients3 0.98% 0.62% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.37% 0.05% 0.00%
Patients with More than one race3 3.42% 3.53% 0.66%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 14.41% 14.74% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.71% 1.91% 3.95%
Unreported/Refused to Report Race and Ethnicity 9.16% 12.12% 12.50%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 12.12%
1 to 24 Hours 24.24%
More Than 24 Hours 63.64%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 21.21%
Vaccine confidence 60.61%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 6.06%
None 33.33%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 91.52%
Average Percent of Health Center Visits Conducted Virtually 17.12%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 39.39%
Number of Mobile Van Sites 14
Number of Pop-up Clinics 41
Number of School-Based Vaccination Sites 6

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 69.70%
None 30.30%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 18.18%
Patient awareness/education 6.06%
Staffing capacity 9.09%
Therapy administration/onsite logistics 12.12%
Other 3.03%
None 69.70%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021